rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kevin Buehler

Director

Company insider

Files Form 4 as: Director, Precision BioSciences.

In numbers

Trades disclosed
24
Buys
3
Sells
0
Bought
$63K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
8 Nov 2019
Last trade
3 Jun 2026
Last filed
5 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
DTIL Precision BioSciencesDirector · Biotechnology · last 3 Jun 20263 buys · 0 sells

Activity over time

1 Dec 2024 – 1 Oct 2026
01Dec 24Jun 25Nov 25May 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 5 Jun 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—20,979 at $0.00filing
3 Jun 2026filed 5 Jun 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—20,979 at $0.00filing
20 May 2026filed 22 May 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—21,000filing
20 May 2026filed 22 May 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—21,000 at $0.00filing
20 May 2026filed 22 May 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—21,000 at $0.00filing
20 May 2026filed 22 May 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—21,000filing
25 Jun 2025filed 27 Jun 2025DTIL Precision BioSciencesBiotechnologySEC FORM 4 Bought$21K5,076 at $4.16filing
3 Jun 2025filed 4 Jun 2025DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—21,000 at $0.00filing
27 May 2025filed 4 Jun 2025DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—9,826 at $0.00filing
27 May 2025filed 4 Jun 2025DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—9,826filing
26 Mar 2025filed 28 Mar 2025DTIL Precision BioSciencesBiotechnologySEC FORM 4 Bought$21K4,523 at $4.67filing
27 Dec 2024filed 31 Dec 2024DTIL Precision BioSciencesBiotechnologySEC FORM 4 Bought$21K4,320 at $4.88filing
4 Jun 2024filed 6 Jun 2024DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—9,826 at $0.00filing
4 May 2024filed 7 May 2024DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,202 at $0.00filing
4 May 2024filed 7 May 2024DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—4,202filing
4 May 2023filed 8 May 2023DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—126,075 at $0.00filing
11 Apr 2023filed 13 Apr 2023DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—5,701 at $0.00filing
11 Apr 2023filed 13 Apr 2023DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—5,701filing
10 May 2022filed 12 May 2022DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—156,951 at $0.00filing
11 Apr 2022filed 13 Apr 2022DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—8,763 at $0.00filing

News

Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026

0 headlines in the last 90 days name Kevin Buehler; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Stanley FrankelDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Geno J. GermanoDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Melinda BrownDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Shari Lisa PireDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Dario ScimecaGeneral Counsel and Secretary · General Counsel and Secretary at Precision Biosciences, filing Form 4 there in the last year